| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | ONTARIO INSTITUTE FOR CANCER RESEARCH INSTITUT ONTARIEN DE RECHERCHE SUR LE CANCER | 661 UNIVERSITY AVE | TORONTO | ON | | | CAN | Human Genome Research | 000 | 3 | 11/13/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,272,864 ) |
| | 2024 | 2024 | ONTARIO INSTITUTE FOR CANCER RESEARCH INSTITUT ONTARIEN DE RECHERCHE SUR LE CANCER | 661 UNIVERSITY AVE | TORONTO | ON | | | CAN | Human Genome Research | 000 | 3 | 9/4/2024 | NON-COMPETING CONTINUATION | $1,272,864 |
|
| Issue Date FY: 2023 ( Subtotal = $1,801,554 ) |
| | 2023 | 2023 | ONTARIO INSTITUTE FOR CANCER RESEARCH INSTITUT ONTARIEN DE RECHERCHE SUR LE CANCER | 661 UNIVERSITY AVE | TORONTO | ON | | | CAN | Trans-NIH Research Support | 001 | 2 | 8/28/2023 | SUPPLEMENT FOR EXPANSION | $174,458 |
| | 2023 | 2023 | ONTARIO INSTITUTE FOR CANCER RESEARCH INSTITUT ONTARIEN DE RECHERCHE SUR LE CANCER | 661 UNIVERSITY AVE | TORONTO | ON | | | CAN | Human Genome Research | 000 | 2 | 8/17/2023 | NON-COMPETING CONTINUATION | $1,533,353 |
| | 2023 | 2023 | ONTARIO INSTITUTE FOR CANCER RESEARCH INSTITUT ONTARIEN DE RECHERCHE SUR LE CANCER | 661 UNIVERSITY AVE | TORONTO | ON | | | CAN | Trans-NIH Research Support | 002 | 2 | 8/31/2023 | SUPPLEMENT FOR EXPANSION | $93,743 |
|
| Issue Date FY: 2022 ( Subtotal = $1,529,838 ) |
| | 2022 | 2022 | ONTARIO INSTITUTE FOR CANCER RESEARCH | 661 UNIVERSITY AVE SUITE 510 | TORONTO | ON | | | CAN | Human Genome Research | 001 | 1 | 9/8/2022 | NEW | $68,641 |
| | 2022 | 2022 | ONTARIO INSTITUTE FOR CANCER RESEARCH | 661 UNIVERSITY AVE SUITE 510 | TORONTO | ON | | | CAN | Human Genome Research | 000 | 1 | 8/18/2022 | NEW | $1,461,197 |
|
|
